Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Imaging for Focal Hepatic Lesions: Systematic Review and Meta-analysis

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2015 Apr 21

PMID 25892885

Citations 14

Authors

You-Wei Li

Zheng-Guang Chen

Ji-Chen Wang

Zong-Ming Zhang

Affiliations

Soon will be listed here.

Abstract

Aim: To evaluate the performance of superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance imaging (MRI) in the detection and characterization of focal hepatic lesions (FHLs).

Methods: This meta-analysis compared relevant studies that were identified by searching PubMed, EMBASE, and the Cochrane Library databases for articles published between January 1988 and September 2014 and that met the following criteria: (1) SPIO-enhanced MRI was conducted to identify FHLs and data were sufficient for pooled analysis using Meta-DiSc 1.4; (2) hepatocellular carcinomas (HCCs) were differentiated from other FHLs; (3) well-differentiated HCCs (WD-HCCs) were contradistinguished from dysplastic nodules; and (4) WD-HCCs were compared with moderately and poorly differentiated HCCs (MD- and PD-HCCs, respectively).

Results: The data obtained from 15 eligible studies yielded a sensitivity of 85% and a specificity of 78% for differentiating between HCCs and other FHLs. The sensitivity was unchanged and the specificity was increased to 87% when non-HCC malignancies were excluded. Comparative analyses between WD-HCCs and MD- and PD-HCCs from seven studies showed a sensitivity of 98% and a specificity of 50% for the diagnosis of MD- and PD-HCCs, and the area under the summary receiver operating characteristics (sROC) curve was 0.97. A comparison between WD-HCCs and dysplastic nodules revealed a sensitivity of 50% and a specificity of 92% for the diagnosis of WD-HCCs and the area under the sROC curve was 0.80.

Conclusion: SPIO-enhanced MRI is useful in differentiating between HCCs and other FHLs.

Citing Articles

Magnetic particle imaging angiography of the femoral artery in a human cadaveric perfusion model.

Hartung V, Gruschwitz P, Augustin A, Grunz J, Kleefeldt F, Peter D Commun Med (Lond). 2025; 5(1):75.

PMID: 40082699 PMC: 11906881. DOI: 10.1038/s43856-025-00794-x.

Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review.

Sharma K, Mohsin M, Mittal P, Ali Z, Fatma N, Upadhyay P Curr Pharm Des. 2024; 30(22):1708-1724.

PMID: 38797901 DOI: 10.2174/0113816128298875240321073907.

Magnetic Relaxation Switching Assay Using IFNα-2b-Conjugated Superparamagnetic Nanoparticles for Anti-Interferon Antibody Detection.

Nikolaev B, Yakovleva L, Fedorov V, Yudintceva N, Ryzhov V, Marchenko Y Biosensors (Basel). 2023; 13(6).

PMID: 37366989 PMC: 10296438. DOI: 10.3390/bios13060624.

Diagnostic and therapeutic roles of iron oxide nanoparticles in biomedicine.

Lu C, Hsiao J Tzu Chi Med J. 2023; 35(1):11-17.

PMID: 36866343 PMC: 9972926. DOI: 10.4103/tcmj.tcmj_65_22.

Clinical Significance of Liver MR Imaging.

Ichikawa S, Goshima S Magn Reson Med Sci. 2023; 22(2):157-175.

PMID: 36725068 PMC: 10086396. DOI: 10.2463/mrms.rev.2022-0100.

References

Chou C, Chen R, Chen W, Lii J . Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging: comparison of Ferucarbotran-enhanced MRI with accumulation-phase FS-T1WI and gadolinium-enhanced MRI. J Chin Med Assoc. 2011; 74(2):62-8. DOI: 10.1016/j.jcma.2011.01.013. View

Kobayashi S, Matsui O, Kamura T, Yamamoto S, Yoneda N, Gabata T . Imaging of benign hypervascular hepatocellular nodules in alcoholic liver cirrhosis: differentiation from hypervascular hepatocellular carcinoma. J Comput Assist Tomogr. 2007; 31(4):557-63. DOI: 10.1097/RCT.0b013e3180305bfb. View

Lau W, Lai E . Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int. 2008; 7(3):237-57. View

Maurea S, Mainenti P, Tambasco A, Imbriaco M, Mollica C, Laccetti E . Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: comparison between gadolinium and superparamagnetic iron oxide contrast media. Quant Imaging Med Surg. 2014; 4(3):181-9. PMC: 4032916. DOI: 10.3978/j.issn.2223-4292.2014.01.02. View

Inoue T, Kudo M, Watai R, Pei Z, Kawasaki T, Minami Y . Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol. 2005; 40(12):1139-47. DOI: 10.1007/s00535-005-1712-y. View

Macarini L, Milillo P, Cascavilla A, Scalzo G, Stoppino L, Vinci R . MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers. Radiol Med. 2009; 114(8):1267-82. DOI: 10.1007/s11547-009-0464-9. View

Zhang X, Liang B, Huang S . [Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma]. Ai Zheng. 2003; 22(7):734-8. View

Okada M, Imai Y, Kim T, Kogita S, Takamura M, Kumano S . Comparison of enhancement patterns of histologically confirmed hepatocellular carcinoma between gadoxetate- and ferucarbotran-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2010; 32(4):903-13. DOI: 10.1002/jmri.22333. View

Kato H, Kanematsu M, Kondo H, Goshima S, Matsuo M, Hoshi H . Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity. J Magn Reson Imaging. 2003; 19(1):76-81. DOI: 10.1002/jmri.10425. View

10.

Suzuki S, Iijima H, Moriyasu F, Sasaki S, Yanagisawa K, Miyahara T . Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI. Hepatol Res. 2004; 29(2):122-126. DOI: 10.1016/j.hepres.2004.02.010. View

11.

Goshima S, Kanematsu M, Kondo H, Shiratori Y, Onozuka M, Moriyama N . Optimal acquisition delay for dynamic contrast-enhanced MRI of hypervascular hepatocellular carcinoma. AJR Am J Roentgenol. 2009; 192(3):686-92. DOI: 10.2214/AJR.08.1255. View

12.

Muhi A, Ichikawa T, Motosugi U, Sou H, Nakajima H, Sano K . Diagnosis of colorectal hepatic metastases: comparison of contrast-enhanced CT, contrast-enhanced US, superparamagnetic iron oxide-enhanced MRI, and gadoxetic acid-enhanced MRI. J Magn Reson Imaging. 2011; 34(2):326-35. DOI: 10.1002/jmri.22613. View

13.

Whiting P, Rutjes A, Reitsma J, Bossuyt P, Kleijnen J . The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003; 3:25. PMC: 305345. DOI: 10.1186/1471-2288-3-25. View

14.

Lim J, Choi D, Cho S, Kim S, Lee W, Lim H . Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology. 2001; 220(3):669-76. DOI: 10.1148/radiol.2203001777. View

15.

Teerasamit W, Saiviroonporn P, Pongpaibul A, Korpraphong P . Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases. J Med Assoc Thai. 2014; 97(5):540-7. View

16.

Yoo H, Lee J, Lee J, Kim S, Kim S, Han J . Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Invest Radiol. 2009; 44(12):800-7. DOI: 10.1097/RLI.0b013e3181bc271d. View

17.

. Terminology of nodular hepatocellular lesions. Hepatology. 1995; 22(3):983-93. DOI: 10.1016/0270-9139(95)90324-0. View

18.

Yoon M, Kim S, Park H, Lee D, Lee J, Han J . Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis. Invest Radiol. 2009; 44(10):641-9. DOI: 10.1097/RLI.0b013e3181ab6e57. View

19.

Park H, Lee J, Kim S, Chang S, Kim S, Han J . Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla. J Magn Reson Imaging. 2009; 29(2):328-35. DOI: 10.1002/jmri.21615. View

20.

Paley M, Mergo P, Torres G, Ros P . Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging. AJR Am J Roentgenol. 2000; 175(1):159-63. DOI: 10.2214/ajr.175.1.1750159. View